EA
IMUX icon

Emerald Acquisition’s Immunic IMUX Stock Holding History

Emerald Acquisition’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$55K Sell
22
-18
-45% -$44.4K ﹤0.01% 2882
2016
Q2 		$99K Buy
+40
New +$131K ﹤0.01% 2833

Other funds holding IMUX

Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Emerald Acquisition's IMUX Position: Q3 2016 in Review

Emerald Acquisition reduced its Immunic (IMUX) stake by 45% in Q3 2016, selling an estimated $44.4K and leaving 22 shares worth $55K. The position accounts for ﹤0.01% of the portfolio, ranked #2882.

Emerald Acquisition first reported a position in IMUX in Q2 2016 and has held it in 2 quarters since. The position peaked at $99K in Q2 2016. 51 funds tracked by Wall St. Rank hold IMUX as of Q3 2016.

  • Emerald Acquisition held 22 shares of Immunic worth $55K as of Q3 2016.
  • Emerald Acquisition sold 18 Immunic shares in Q3 2016, an estimated $44.4K.
  • Immunic made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2882 holding.
  • Emerald Acquisition first reported a position in Immunic in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Immunic position peaked at $99K in Q2 2016.
  • 51 funds tracked by Wall St. Rank held Immunic as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.